JPS54130516A - Acyllnnacetylmuramylpeptide derivativeeantigen combination - Google Patents

Acyllnnacetylmuramylpeptide derivativeeantigen combination

Info

Publication number
JPS54130516A
JPS54130516A JP3790178A JP3790178A JPS54130516A JP S54130516 A JPS54130516 A JP S54130516A JP 3790178 A JP3790178 A JP 3790178A JP 3790178 A JP3790178 A JP 3790178A JP S54130516 A JPS54130516 A JP S54130516A
Authority
JP
Japan
Prior art keywords
derivativeeantigen
acyllnnacetylmuramylpeptide
combination
derivativeeantigen combination
acyllnnacetylmuramylpeptide derivativeeantigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3790178A
Other languages
Japanese (ja)
Inventor
Yuuichi Yamamura
Chiyuuzou Kishimoto
Yoshikatsu Hirai
Ichirou Azuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP3790178A priority Critical patent/JPS54130516A/en
Priority to GB7909795A priority patent/GB2020665A/en
Priority to DE19792912865 priority patent/DE2912865A1/en
Priority to FR7908265A priority patent/FR2421178A1/en
Publication of JPS54130516A publication Critical patent/JPS54130516A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP3790178A 1978-03-31 1978-03-31 Acyllnnacetylmuramylpeptide derivativeeantigen combination Pending JPS54130516A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP3790178A JPS54130516A (en) 1978-03-31 1978-03-31 Acyllnnacetylmuramylpeptide derivativeeantigen combination
GB7909795A GB2020665A (en) 1978-03-31 1979-03-20 Acyl-N-acetylmuramylpeptide- antigen conjugate
DE19792912865 DE2912865A1 (en) 1978-03-31 1979-03-30 ACYL-N-ACETYLMURAMYL PEPTIDE DERIVATIVE ANTIGEN CONJUGATE AND METHOD FOR ITS PRODUCTION
FR7908265A FR2421178A1 (en) 1978-03-31 1979-04-02 CONJUGATE OF AN ACYL-N-ACETYLMURAMYL-PEPTIDE DERIVATIVE AND AN ANTIGEN, ITS PREPARATION PROCESS AND ITS THERAPEUTIC APPLICATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3790178A JPS54130516A (en) 1978-03-31 1978-03-31 Acyllnnacetylmuramylpeptide derivativeeantigen combination

Publications (1)

Publication Number Publication Date
JPS54130516A true JPS54130516A (en) 1979-10-09

Family

ID=12510433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3790178A Pending JPS54130516A (en) 1978-03-31 1978-03-31 Acyllnnacetylmuramylpeptide derivativeeantigen combination

Country Status (4)

Country Link
JP (1) JPS54130516A (en)
DE (1) DE2912865A1 (en)
FR (1) FR2421178A1 (en)
GB (1) GB2020665A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025089217A1 (en) * 2023-10-23 2025-05-01 株式会社ヤクルト本社 COMPOUND FOR USE AS SUBSTRATE FOR EVALUATING ACTIVITY OF γ-D-GLUTAMYL-L-LYSYL ENDOPEPTIDASE

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482959A2 (en) * 1979-06-29 1981-11-27 Rhone Poulenc Ind Merrifield synthesis of immunostimulant and adjuvant tri:peptide(s) - produces fatty acid acrylated l-alanine d-glutamic acid 2-lysine or 2,6-di:amino-pimelamic acid cpds.
FR2482958A2 (en) * 1979-06-29 1981-11-27 Rhone Poulenc Ind Immunostimulant and adjuvant L-alanyl-D-glutamyl tri:peptide derivs. - in which the C-terminal aminoacid is l-lysine or di:amino-pimelic acid and which has a fatty acid n-acyl gp.
DK156252C (en) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co METHOD OF ANALOGUE FOR THE PREPARATION OF DI, TRIAL OR TETRAPEPTIDE DERIVATIVES OR SALTS THEREOF
DE3070278D1 (en) * 1979-10-11 1985-04-18 Fujisawa Pharmaceutical Co Peptides, processes for their preparation and pharmaceutical compositions containing them
FR2477551A1 (en) * 1980-03-10 1981-09-11 Anvar NEW DERIVATIVES OF A-TREHALOSE AND MEDICAMENTS CONTAINING SAME
FR2546756B1 (en) * 1983-06-03 1985-11-29 Centre Nat Rech Scient NOVEL IMMUNOSTIMULATING DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
US4877795A (en) * 1987-01-30 1989-10-31 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
GB2579253A (en) * 2018-11-28 2020-06-17 Pedanius Therapeutics Ltd Antibacterial antisense agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54141718A (en) * 1978-02-24 1979-11-05 Ciba Geigy Ag Novel antigen derivative and its manufacture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH564031A5 (en) * 1968-03-29 1975-07-15 Anvar
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54141718A (en) * 1978-02-24 1979-11-05 Ciba Geigy Ag Novel antigen derivative and its manufacture

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025089217A1 (en) * 2023-10-23 2025-05-01 株式会社ヤクルト本社 COMPOUND FOR USE AS SUBSTRATE FOR EVALUATING ACTIVITY OF γ-D-GLUTAMYL-L-LYSYL ENDOPEPTIDASE

Also Published As

Publication number Publication date
DE2912865A1 (en) 1979-10-18
GB2020665A (en) 1979-11-21
FR2421178A1 (en) 1979-10-26

Similar Documents

Publication Publication Date Title
CS520079A2 (en) Nosna soustava snimaci hlavice
DE2967509D1 (en) Skin-equivalent
BG27580A1 (en) Two- poled pelvis- thight articulation- set
CS74479A2 (en) Omezovac nadmerne proudove vodivosti televizni reprodukcni obrazovky
GB2013938B (en) Servocontrollers
CS333379A2 (en) Upinaci zarizeni
CS615079A2 (en) Zpusob vyroby inhibitoru enzymu
CS613879A2 (en) Zpusob vyroby fenylchinolizidinu
JPS54130516A (en) Acyllnnacetylmuramylpeptide derivativeeantigen combination
CS846479A2 (en) Tkaci stroj
CS290179A2 (en) Plynova vybojka
GB2014109B (en) Exavators
GB2030947B (en) Bouys
EP0004713A3 (en) Twinski
GB1550031A (en) Hairdriers
GB2013592B (en) Play-vehicle
GB2014996B (en) Arylacetamidocephalosporins
EG13808A (en) Carbamoyl-oximes
GB2012937B (en) Refigerators
GB1555634A (en) Sportsballs
GB1558045A (en) Drumtensioning
CS686179A2 (en) Zpusob vyroby fenylchinolizidinu
CS839779A2 (en) Zpusob vyroby benzimidazol-karbamatu
CS556679A2 (en) Zpusob vyroby derivatu chlorambucilu
BG31541A1 (en) Ornitopter